IRIS
BONI, CAROLINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.776
NA - Nord America 2.757
EU - Europa 1.519
SA - Sud America 425
AF - Africa 161
OC - Oceania 13
Totale 7.651
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.665
SG - Singapore 954
CN - Cina 643
VN - Vietnam 549
IT - Italia 429
BR - Brasile 335
IE - Irlanda 235
HK - Hong Kong 224
DE - Germania 187
SE - Svezia 169
FR - Francia 124
ZA - Sudafrica 104
TR - Turchia 86
NL - Olanda 80
FI - Finlandia 74
IN - India 61
CA - Canada 58
RU - Federazione Russa 45
GB - Regno Unito 40
BD - Bangladesh 36
KR - Corea 35
AR - Argentina 34
JP - Giappone 31
MX - Messico 24
IQ - Iraq 22
CI - Costa d'Avorio 18
AT - Austria 17
ID - Indonesia 16
PK - Pakistan 16
UA - Ucraina 14
UZ - Uzbekistan 14
BE - Belgio 13
PH - Filippine 13
AU - Australia 12
CO - Colombia 12
LT - Lituania 12
EC - Ecuador 11
MA - Marocco 11
TW - Taiwan 11
DK - Danimarca 10
ES - Italia 10
PL - Polonia 10
TH - Thailandia 10
VE - Venezuela 10
KE - Kenya 9
SA - Arabia Saudita 9
CZ - Repubblica Ceca 7
PY - Paraguay 7
CH - Svizzera 6
BG - Bulgaria 5
EG - Egitto 5
IR - Iran 5
RO - Romania 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
AZ - Azerbaigian 4
IL - Israele 4
JO - Giordania 4
LV - Lettonia 4
MY - Malesia 4
PE - Perù 4
PT - Portogallo 4
TN - Tunisia 4
BO - Bolivia 3
CL - Cile 3
CR - Costa Rica 3
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
TZ - Tanzania 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CM - Camerun 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
JE - Jersey 1
KW - Kuwait 1
LB - Libano 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
Totale 7.643
Salva come PNG Salva come JPEG
Città #
Singapore 485
Dallas 413
Ashburn 350
San Jose 275
Santa Clara 260
Dublin 234
Hong Kong 208
Chandler 177
Ho Chi Minh City 153
Parma 145
Beijing 140
Hanoi 137
Johannesburg 95
Boardman 93
New York 91
Munich 85
Dearborn 79
Los Angeles 70
Shanghai 70
Izmir 65
Ann Arbor 55
Milan 55
Lauterbourg 51
São Paulo 36
Hefei 34
Nanjing 34
Princeton 34
Haiphong 32
Wilmington 31
Turku 28
Buffalo 27
Frankfurt am Main 26
Columbus 25
Chicago 24
Council Bluffs 23
Moscow 23
Da Nang 22
Tokyo 21
Toronto 21
Bologna 20
Abidjan 18
Rio de Janeiro 18
Shenyang 18
Nuremberg 17
Houston 16
Montreal 16
The Dalles 16
Guangzhou 15
Reggio Emilia 15
Seoul 15
Grafing 14
Helsinki 14
Hải Dương 14
London 14
Nanchang 14
Brussels 13
Hebei 13
Seattle 13
Tashkent 13
Jacksonville 12
Phoenix 12
Baghdad 11
Bremen 11
Changsha 11
Orem 11
Rome 11
Vienna 11
Curitiba 10
Denver 10
Düsseldorf 10
Bengaluru 9
Brooklyn 9
Can Tho 9
Jakarta 9
Limena 9
San Francisco 9
Montespertoli 8
Nairobi 8
Taastrup 8
Tianjin 8
Warsaw 8
Zhengzhou 8
Bangkok 7
Boston 7
Chennai 7
Hangzhou 7
Jinan 7
Mexico City 7
Modena 7
Ottawa 7
Biên Hòa 6
Dhaka 6
Istanbul 6
Jiaxing 6
Norwalk 6
Paris 6
Porto Alegre 6
Quảng Ngãi 6
Rockville 6
Amsterdam 5
Totale 4.870
Salva come PNG Salva come JPEG
Nome #
A novel enhancing effect of SARS-CoV-2 mutations on anti-viral CD8 T cell responses 303
FUNCTIONAL AND TRANSCRIPTIONAL RESTORATION OF EXHAUSTED VIRUS-SPECIFIC T LYMPHOCYTES FROM PATIENTS WITH CHRONIC HEPATITIS B 282
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection 252
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B 245
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 191
Therapeutic potential of co-signaling receptor modulation in hepatitis B 174
Metabolic regulation of the HBV-specific T cell function 173
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches 168
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations 167
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B 157
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis 157
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 156
TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues 154
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B 154
PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines 149
Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection 149
HBV immune-therapy: From molecular mechanisms to clinical applications 148
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection 145
Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm 144
Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection 141
T cell regulation in HBV-related chronic liver disease 141
The good and the bad of natural killer cells in virus control: Perspective for anti-HBV therapy 137
Antigen Load and T Cell Function: A Challenging Interaction in HBV Infection 131
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro 131
Unraveling the multifaceted nature of cd8 t cell exhaustion provides the molecular basis for therapeutic t cell reconstitution in chronic hepatitis b and c 131
Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer 127
What Is the Current Status of Hepatitis B Virus Viro-Immunology? 126
Early kinetics of innate and adaptive immune responses during hepatitis B virus infection 122
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B 120
Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens 119
Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming 118
Contribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humans 116
FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses 111
Comparative pathogenesis of HBV and HCV 107
Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine development 107
Mobilizing monocytes to cross-present circulating viral antigen in chronic infection 106
Comment on ‘End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB’ 105
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection 101
The Characteristics of the Cell-Mediated Immune Response Identify Different Profiles of Occult Hepatitis B Virus Infection 100
Antiviral cell-mediated immune responses during hepatitis B and hepatitis C virus infections 96
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection 94
Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C 94
Effector CD8(+) T cell-derived interleukin-10 enhances acute liver immunopathology 94
Editorial: Epigenetic and metabolic regulation of immunity during infection or cancer and associated immune biomarkers 92
Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B 92
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B 92
Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells 91
Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections 88
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy 87
Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B 87
Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues 86
High CD49a+ NK cell infiltrate is associated with poor clinical outcomes in Hepatocellular Carcinoma 84
Hepatitis B virus specific immune response: From antigen recognition to liver damage 83
T and NK Cell-Based Immunotherapy in Chronic Viral Hepatitis and Hepatocellular Carcinoma 82
The scientific basis of combination therapy for chronic hepatitis B functional cure 81
Immunopathogenesis of hepatitis C virus infection 79
Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor 73
T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection 71
Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire 60
HBV antigens quantity: duration and effect on functional cure 58
Immunopathogenesis of hepatitis B 56
TGF-β-driven NK Cells plasticity in hepatocellular carcinoma 52
Transcriptional and functional HBV-specific CD8 T cell changes from disease to functional cure in HBeAg-negative chronic hepatitis B 35
Totale 7.772
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.346
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.346
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202139 0 0 0 0 0 0 0 0 0 15 9 15
2021/2022198 8 4 3 26 20 21 11 13 13 4 11 64
2022/2023771 82 66 42 49 58 78 15 40 258 6 40 37
2023/2024548 27 49 27 52 31 119 56 28 25 35 37 62
2024/20251.912 63 91 102 127 200 234 110 127 232 136 163 327
2025/20263.689 348 568 390 296 470 210 405 138 601 263 0 0
Totale 7.772